Intravenous iron therapy for patients with heart failure: a meta-analysis stratified by chronic kidney disease status.
- 2026-03-27
- Meta-Analysis · n = 7,009
- BMC cardiovascular disorders 26(1)
- Yiran Du
- Yingnan Liang
- Jie Lv
- Zhen Wang
- Xiaowen Li
- Zhenjie Chen
- Jingwei Zhou
- PubMed: 41896739
- DOI: 10.1186/s12872-026-05672-5
- High evidence
- Clinical
heart failure hospitalization or cardiovascular death (RR = 0.85, 95% CI: 0.75–0.98, P = 0.02) in HF-CKD patients as compared with the control group
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes